[
1. TANASE A., TOMULEASA C., MARCULESCU A., BARDAS A., COLITA A, ORBAN C., et al., Haploidentical donors: can faster transplantation be life-saving for patients with advanceddisease? Acta Haematol. 2016; 135(4):211-6.10.1159/00044346926914538
]Search in Google Scholar
[
2. BRAMMER J.E., KHOURI I., GABALLA S., ANDERLINI P., TOMULEASA C., AHMED S., et al., Outcomes of haploidentical stem cell transplantation for lymphoma with melphalan-based conditioning. Biol Blood Marrow Transplant. 2016; 22(3):493-8.10.1016/j.bbmt.2015.10.01526497906
]Search in Google Scholar
[
3. PAGANO L., CAIRA M., CANDONI A., OFFIDANI M., FIANCHI L., MARTINO B., et al., The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91:1068.
]Search in Google Scholar
[
4. CHAMILOS G., LUNA M., LEWIS R.E., BODEY G.P., CHEMALY R., TARRAND J.J., et al., Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91:986.
]Search in Google Scholar
[
5. HACHEM R., HANNA H., KONTOYIANNIS D., JIANG Y., RAAD I., The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 2008; 112:2493.10.1002/cncr.2346618412153
]Search in Google Scholar
[
6. CORNELY O.A., GACHOT B., AKAN H., BASSETTI M., UZUN O., KIBBLER C., et al., Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin Infect Dis 2015; 61:324.10.1093/cid/civ29325870323
]Search in Google Scholar
[
7. PAGANO L., AKOVA M., DIMOPOULOS G., HERBRECHT R., DRGONA L., BLIJLEVENS N., Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 2011; 66 Suppl 1:i5.10.1093/jac/dkq43721177404
]Search in Google Scholar
[
8. FREIFIELD A.G., BOW E.J., SEPKOWITZ K.A., BOECKH M.J., ITO J.I., MULLEN C.A., et al., Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 2011; 52:e56.10.1093/cid/cir07321258094
]Search in Google Scholar
[
9. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Prevention and treatment of cancer-related infections. Version 2. 2014. http://www.nccn.org (Accessed on July 24, 2016).
]Search in Google Scholar
[
10. MAERTENS J., MARCHETTI O., HERBRECHT R., CORNELY O.A., FLUCKIGER U., FRERE P. et al., European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 update. Bone Marrow Transplant 2011; 46:709.10.1038/bmt.2010.17520661235
]Search in Google Scholar
[
11. CORNELY O.A., BOHME A., BUCHHEIDT D., EINSELE H., HEINZ W.J., KARTHAUS M., et al., Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica 2009; 94:113.10.3324/haematol.11665262542719066334
]Search in Google Scholar
[
12. SEGAL B.H., FREIFIELD A.G., BADEN L.R., BROWN A.E., CASPER C., DUBBERKE E., GELFAND M., et al., Prevention and treatment of cancer-related infections. J Natl Compr Cancer Netw 2008, 6(2):122-174.10.6004/jnccn.2008.001318319048
]Search in Google Scholar
[
13. CICHRA A., MAKARYUS M., CHAUDHRI P., NARASIMHAN M., Ultrasound for the pulmonary consultant. Clin Med Insights Circ Respir Pulm Med. 2016; 10:1-9.
]Search in Google Scholar
[
14. SPERANDEO M., FILABOZZI P., VARRIALE A., CARNEVALE V., PIATELLI M.L., SPERANDEO G., et al., Role of thoracic ultrasound in the assessment of pleural and pulmonary diseases. J Ultrasound. 2008; 11(2):39-46.10.1016/j.jus.2008.02.001355324023396553
]Search in Google Scholar
[
15. DOHNER H., WEISDORF D.J., BLOOMFIELD C.D., Acute myeloid leukemia. N Engl J Med. 2015; 373(12):1136-52.10.1056/NEJMra140618426376137
]Search in Google Scholar
[
16. FISCHER R.I., GAYNOR E.R., DAHLBERG S., OKEN M.M., GROGAN T.M., MIZE E.M., et al., Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993; 328(14):1002-6.10.1056/NEJM1993040832814047680764
]Search in Google Scholar
[
17. JAGANNATH S., DURIE B.G., WOLF J., CAMACHO E., IRWIN D., LUTZKY J., et al., Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma. Br J Haematol. 2005; 129(6):776-83.10.1111/j.1365-2141.2005.05540.x15953004
]Search in Google Scholar
